エリスロポエチンのグローバル市場動向...市場調査レポートについてご紹介

1. Analyst View
2. Research Methodology
3. Industry Trends and Drivers
3.1 Increasing Incidence of Chronic Diseases
3.2 Increasing Affordability
3.3 Changing Lifestyles
3.4 Effective Delivery Methods: Improving the Reach of Therapy
4. Challenges
4.1 High Prices
4.2 Numerous Drugs Patent Expiries Provide Opportunity for Biosimilars
5. Global Protein Therapeutics Market
5.1 Protein Therapeutics Market Vs Pharmaceutical Market
5.2 Current and Future Market Analysis for 2020
5.2.1 Market Segmentation
6. Erythropoietin Market – Introduction
7. Global Erythropoietin Market Outlook to 2020
8. Market Segmentation
8.1 By Application
8.2 By Geographical Markets
8.3 By Drugs
9. Competitive Landscape
9.1 Share of Major Players
9.2 Key Players
9.2.1 Roche Group
9.2.2 Amgen Inc.
9.2.3 Johnson & Johnson

List of Figures:

Figure 5-1: Global – Protein Therapeutics vs Pharmaceutical Market (Billion US$), 2014
Figure 5-2: Global – Protein Therapeutics Market (Billion US$), 2014-2020
Figure 5-3: Global – Protein Therapeutics Market by Segment (%), 2014
Figure 7-1: Global – Erythropoietin Market (Billion US$), 2014-2020
Figure 8-1: Global – Number of Patients on Dialysis (Million), 2012-2014
Figure 8-2: Global – Breakup of Patients on Dialysis by Region (%), 2013
Figure 8-3: Global – Number of New Cancer Cases (Million), 2012 & 2030
Figure 8-4: Global – Breakup of New Cancer Cases by Region (%), 2012
Figure 8-5: Global – Share of US in EPO Market (2014)
Figure 9-1: Market Share of Major Players in the Erythropoietin Market (%), 2014
Figure 9-2: Roche Group – Break up of Revenue by Geography (%), 2014
Figure 9-3: Amgen Inc. – Break up of Revenue by Geography (%), 2014
Figure 9-4: Johnson & Johnson – Break up of Revenue by Geography (%), 2014

List of Tables:

Table 4-1: Some of the Erythropoietin Drugs which are Patented
Table 8-1: US – Sales of Key EPO Products (Billion US$), 2012-2014
Table 8-2: Global – Key Players and Drugs in Erythropoietin Alfa Market (Million US$), 2014
Table 8-3: Global – Key Players and Drugs in Erythropoietin Beta Market (Million US$), 2014
Table 8-4: Global – Key Players and Drugs in Darbepoetin Market (Million US$), 2014
Table 9-1: Roche Group – Key EPO Products
Table 9-2: Roche Group – Financial Performance (Million US$), 2012-2014
Table 9-3: Roche Group – Strengths and Weaknesses
Table 9-4: Amgen Inc. – Key EPO Products
Table 9-5: Amgen Inc. – Key Financials (Million US$), 2012-2014
Table 9-6: Amgen Inc. – Strengths and Weaknesses
Table 9-7: Johnson & Johnson – Key EPO Products
Table 9-8: Johnson & Johnson – Key Financials (Million US$), 2012-2014
Table 9-9: Johnson & Johnson – Strengths and Weaknesses